The current PE ratio for Astrana Health stock as of Mar 19, 2025 is 34.63. This is calculated based on the TTM EPS of $0.91 and the stock price of $31.51 per share. The current PE ratio is about the same compared to the last four quarters average.
The average historical PE ratio of Astrana Health for the last eight years is 39.13. The current P/E ratio of 34.63 is 12% lower than the historical average. Looking back at the last eight years, ASTH's PE ratio peaked in the Sep 2019 quarter at 160.18, when the price was $17.62 and the EPS was $0.11. The lowest point was in the Mar 2018 quarter, when it reached 17.72 with a price of $15.95 and an EPS of $0.9.
Maximum annual increase: 163.81% in 2021
Maximum annual decrease: -60.49% in 2020
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 34.65 | 17.62% | $31.53 | $0.91 |
2023 | 29.46 | -0.44% | $38.3 | $1.3 |
2022 | 29.59 | -36.77% | $29.59 | $1 |
2021 | 46.8 | 163.81% | $73.48 | $1.57 |
2020 | 17.74 | -60.49% | $18.27 | $1.03 |
2019 | 44.9 | -25.35% | $18.41 | $0.41 |
2018 | 60.15 | 153.16% | $19.85 | $0.33 |
2017 | 23.76 | N/A | $24 | $1.01 |
2016 | N/A | N/A | N/A | $0.46 |
2015 | N/A | N/A | N/A | -$0.37 |
2014 | N/A | N/A | N/A | -$1.37 |
2013 | N/A | N/A | N/A | -$2.7 |
2012 | N/A | N/A | N/A | -$0.2 |
2011 | N/A | N/A | N/A | -$0.1 |
2010 | N/A | N/A | N/A | -$0.1 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | 34.65 | -21.66% | $31.53 | $0.91 |
Sep 2024 | 44.23 | 57.01% | $57.94 | $1.31 |
Jun 2024 | 28.17 | -11.44% | $40.56 | $1.44 |
Mar 2024 | 31.81 | 7.98% | $41.99 | $1.32 |
Dec 2023 | 29.46 | -10.24% | $38.3 | $1.3 |
Sep 2023 | 32.82 | 2.82% | $30.85 | $0.94 |
Jun 2023 | 31.92 | -14.22% | $31.6 | $0.99 |
Mar 2023 | 37.21 | 25.75% | $36.47 | $0.98 |
Dec 2022 | 29.59 | -2.12% | $29.59 | $1 |
Sep 2022 | 30.23 | 20.63% | $39 | $1.29 |
Jun 2022 | 25.06 | -19.34% | $38.59 | $1.54 |
Mar 2022 | 31.07 | -33.61% | $48.47 | $1.56 |
Dec 2021 | 46.8 | -16.22% | $73.48 | $1.57 |
Sep 2021 | 55.86 | 17.4% | $91.05 | $1.63 |
Jun 2021 | 47.58 | 116.08% | $62.81 | $1.32 |
Currently, ASTH's PE ratio is higher than its 3 and 5-year averages.
ASTH's PE ratio stands higher than its peer stock NHC.
Stock name | PE ratio | Market cap |
---|---|---|
NHC National Healthcare Corp | 14.28 | $1.46B |
ASTH Astrana Health Inc. | 34.63 | $1.77B |
INNV InnovAge Holding Corp | N/A | $467.94M |
As of Mar 19, 2025, ASTH stock has a price to earnings ratio of 34.63.
Over the last 3 years, the average price to earnings ratio for ASTH stock is 32.19.
Over the last 5 years, the average price to earnings ratio for ASTH stock is 32.31.
Over the last eight years, the quarterly PE ratio reached its highest level at 160.18 in the Sep 2019 quarter.
The current PE ratio of ASTH is 12% lower than the 8-year historical average.
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Mar 19, 2025), Astrana Health's share price is $31.51. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.91. Therefore, Astrana Health's PE ratio for today is 34.63. PE RATIO(34.63) = STOCK PRICE($31.51) / TTM EPS($0.91)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.